Fig. 1From: Aortic valve replacement in a patient with MPO-ANCA-positive Goodpasture diseasePreoperative and postoperative course in MPO-ANCA, anti-GBM-antibody, and KL-6. The patient received immunosuppressive therapy and plasmapheresis for MPO-ANCA-positive GD before 18 M prior to AVR. MPO-ANCA myeloperoxidase-anti-neutrophil cytoplasmic antibody, anti-GBM-antibody anti-glomerular basement membrane antibodies, AVR aortic valve replacement, GD Goodpasture disease, M monthsBack to article page